STOCK TITAN

Ayr Wellness Inc. Stock Price, News & Analysis

AYRWF OTC

Welcome to our dedicated page for Ayr Wellness news (Ticker: AYRWF), a resource for investors and traders seeking the latest updates and insights on Ayr Wellness stock.

This page provides news coverage for Ayr Wellness Inc. (AYRWF), a vertically integrated cannabis company currently undergoing CCAA (Companies' Creditors Arrangement Act) proceedings and financial restructuring. The news feed tracks developments in the company's bankruptcy protection process, creditor negotiations, and operational updates during reorganization.

Cannabis companies in financial restructuring generate news across several categories. Regulatory filings announcements detail updates to the CCAA proceedings, extensions of waiver agreements with lenders, and delays in financial reporting. Operational news covers facility launches, market expansions, or contractions as the company restructures its footprint. Management changes often occur during reorganization periods as companies bring in restructuring specialists or respond to creditor demands.

For companies undergoing bankruptcy proceedings, news monitoring becomes particularly important as developments can materially impact the reorganization outcome and shareholder value. Key events to watch include announcements of restructuring support agreements, court approvals of reorganization plans, bridge financing arrangements, and potential acquisition interest from competitors or financial buyers.

The cannabis industry's complex regulatory environment and capital-intensive nature create unique restructuring dynamics. News coverage helps investors understand how the company navigates creditor negotiations while maintaining state licenses and operational compliance across multiple jurisdictions. Our real-time news aggregation ensures you receive timely updates on material developments affecting Ayr Wellness's restructuring process.

Rhea-AI Summary

AYR Wellness (OTCQX: AYRWF) has secured an extension to its Limited Waiver Agreement with majority holders of its senior secured notes until July 18, 2025. The waiver addresses defaults related to delayed Q1 2025 financial filings and certain payment defaults on outstanding debt.

The temporary waiver prevents noteholders from exercising default-related rights while the company continues negotiations with senior lenders and explores strategic options to strengthen its capital structure. AYR continues to operate normally and evaluate growth opportunities while working with stakeholders to address its financial obligations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.13%
Tags
none
-
Rhea-AI Summary

AYR Wellness (OTCQX: AYRWF) has received a Notification of Disposition of Collateral from Anthony J. DePaul regarding potential reclamation and sale of its interest in PA Natural Medicine LLC, which operates three medical cannabis dispensaries in Pennsylvania. The notice cites alleged defaults under the Pledge Agreement.

Additionally, the company has secured a Second Amendment to its Limited Waiver Agreement with senior noteholders, extending the temporary waiver period to July 11, 2025. This extension relates to defaults from delayed Q1 2025 financial filings and certain payment defaults, providing AYR additional time for negotiations with senior lenders and exploration of capital structure alternatives.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.99%
Tags
none
-
Rhea-AI Summary

AYR Wellness (OTCQX: AYRWF), a leading U.S. multi-state cannabis operator, announced it has missed its June 30, 2025 interest payment on its outstanding senior notes. If the payment is not made by July 30, 2025, it will trigger an event of default.

The company's Interim CEO Scott Davido stated this is a strategic step in their ongoing debt restructuring efforts. AYR is currently in discussions with majority noteholders regarding capital structure alternatives as part of a broader strategic review announced on May 30, 2025. The company maintains that the missed interest payment is not expected to impact its operational capabilities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.25%
Tags
none
Rhea-AI Summary

AYR Wellness (OTCQX: AYRWF), a vertically integrated U.S. multi-state cannabis operator, announced delays in filing its Q1 2025 interim financial statements and related documents. The delay is attributed to ongoing negotiations with creditors and assessment of debt obligation classifications with senior lenders.

The company is currently under a failure-to-file cease-trade order (FFCTO) issued by the Ontario Securities Commission, which prohibits trading of AYR's securities in Canadian jurisdictions and has resulted in a trading suspension on the Canadian Securities Exchange. AYR is conducting a broader strategic review to address upcoming payment obligations and support its long-term strategic plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-20.09%
Tags
-
Rhea-AI Summary
AYR Wellness has extended its Limited Waiver Agreement with senior noteholders from June 19, 2025, to July 3, 2025. The extension follows the Original Agreement dated June 6, 2025, which provided a waiver for defaults related to delayed Q1 2025 financial filings and potential payment defaults. The Majority Holders of AYR's senior secured notes have agreed to temporarily refrain from exercising their default-related rights during this period. This extension gives AYR additional time to continue negotiations with senior lenders and explore strategic options to strengthen its capital structure. The Extended Agreement is not a permanent waiver of defaults but rather provides more time for dialogue and strategic planning.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-36.97%
Tags
none
-
Rhea-AI Summary
AYR Wellness (AYRWF) has announced a delay in filing its Q1 2025 interim financial statements and related documents beyond the expected date of June 13, 2025. The delay stems from ongoing negotiations with creditors and the assessment of debt obligation classifications with a senior lenders committee. Due to this delay, the Ontario Securities Commission has issued a failure-to-file cease-trade order (FFCTO), suspending trading of AYR's securities on the Canadian Securities Exchange. The company is undergoing a strategic review process to address upcoming payment obligations and plans to provide an update on the filing timeline by June 27, 2025. Despite the trading suspension, AYR expects to continue normal business operations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary
AYR Wellness has entered into a Limited Waiver Agreement with majority holders of its senior secured notes, providing temporary relief through June 19, 2025, from certain defaults including delayed Q1 2025 financial filings and potential payment defaults. The agreement restricts noteholders from exercising default-related rights during the waiver period but does not constitute a permanent solution. The company is actively negotiating with senior lenders and evaluating strategic alternatives to address its capital structure and upcoming payment obligations. This temporary arrangement allows AYR additional flexibility to continue strategic discussions while maintaining normal business operations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.21%
Tags
none
-
Rhea-AI Summary
AYR Wellness, a leading U.S. multi-state cannabis operator, has announced that the Ontario Securities Commission (OSC) has issued a Failure to File Cease Trade Order (FFCTO) effective June 5, 2025. This order comes after the company failed to file its required interim financial statements and related documents for Q1 2025 by the deadline. The FFCTO prohibits all trading of AYR securities in Canada, with limited exceptions for non-insider beneficial security holders who can sell through foreign regulated markets. The company is actively working to complete its outstanding filings and maintains that the FFCTO will not affect its regular business operations or ability to serve customers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
27.43%
Tags
none
-
Rhea-AI Summary
AYR Wellness (AYRWF) has announced it will miss the May 30, 2025 deadline for filing its Q1 2024 financial statements and MD&A. The company expects a cease-trade order (CTO) that will prohibit trading of its securities in Canadian jurisdictions and suspend trading on the Canadian Securities Exchange. AYR has initiated a strategic review process due to upcoming creditor payment obligations and has retained Moelis & Company LLC as its investment banker. The company is in negotiations with a committee representing over 50% of its outstanding senior secured notes due December 2026. AYR anticipates filing the required documents by June 13, 2025, and states the CTO will not affect normal business operations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-53.89%
Tags
Rhea-AI Summary

AYR Wellness (CSE: AYR.A, OTCQX: AYRWF) announced significant leadership changes, with Steven M. Cohen stepping down as Interim Chief Executive Officer effective April 04, 2025. The board has appointed Scott Davido as the new Interim CEO.

Cohen, who served as Interim CEO since September 18, 2024, will remain as an advisor to support the transition. Davido joins from Ankura Consulting Group, where he served as senior managing director. His extensive experience includes previous roles as Interim CEO of DCL , CEO of Advantage Rent a Car, and CEO of Experience.com, along with senior executive positions at Calpine and NRG Energy.

Board Chairman Louis Karger acknowledged Cohen's contributions in initiating organizational evolution and welcomed Davido's appointment, citing his track record in positioning companies for sustained success and executing strategic initiatives.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-23.53%
Tags
none

FAQ

What is the current stock price of Ayr Wellness (AYRWF)?

The current stock price of Ayr Wellness (AYRWF) is $0.0298 as of January 12, 2026.

What is the market cap of Ayr Wellness (AYRWF)?

The market cap of Ayr Wellness (AYRWF) is approximately 13.3M.
Ayr Wellness Inc.

OTC:AYRWF

AYRWF Rankings

AYRWF Stock Data

13.32M
92.33M
15.17%
16.25%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Miami